Related Experiment Video
Updated: Jan 25, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia
Nikhil Panicker1,2,3, Souvarish Sarkar1, Dilshan S Harischandra1
1Parkinson Disorders Research Program, Iowa Center for Advanced Neurotoxicology, Department of Biomedical Sciences, Iowa State University, Ames, IA.
Abstract:
Persistent microglia-mediated neuroinflammation is a major pathophysiological contributor to the progression of Parkinson's disease (PD), but the cell-signaling mechanisms governing chronic neuroinflammation are not well understood. Here, we show that Fyn kinase, in conjunction with the class B scavenger receptor CD36, regulates the microglial uptake of aggregated human α-synuclein (αSyn), which is the major component of PD-associated Lewy bodies. αSyn can effectively mediate LPS-independent priming and activation of the microglial NLRP3 inflammasome. Fyn kinase regulates both of these processes; it mediates PKCδ-dependent NF-κB-p65 nuclear translocation, leading to inflammasome priming, and facilitates αSyn import into microglia, contributing to the generation of mitochondrial reactive oxygen species and consequently to inflammasome activation. In vivo experiments using A53T and viral-αSyn overexpression mouse models as well as human PD neuropathological results further confirm the role of Fyn in NLRP3 inflammasome activation. Collectively, our study identifies a novel Fyn-mediated signaling mechanism that amplifies neuroinflammation in PD.
Insights
Persistent microglia activation drives Parkinson's disease (PD) progression. This study reveals Fyn kinase and CD36 control microglial uptake of alpha-synuclein, amplifying neuroinflammation via the NLRP3 inflammasome.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Persistent microglia-mediated neuroinflammation is a key driver of Parkinson's disease (PD) pathogenesis.
- The precise cell-signaling pathways governing chronic microglial activation in PD remain incompletely understood.
Purpose of the Study:
- To elucidate the signaling mechanisms by which microglia contribute to Parkinson's disease progression.
- To investigate the role of Fyn kinase and CD36 in microglial response to aggregated alpha-synuclein (αSyn).
Main Methods:
- Investigated the interaction between Fyn kinase, CD36, and aggregated αSyn in microglial activation.
- Utilized LPS-independent priming and activation assays for the NLRP3 inflammasome.
- Employed in vivo mouse models (A53T and viral-αSyn overexpression) and human PD brain tissue analysis.
Main Results:
- Fyn kinase and CD36 regulate microglial uptake of aggregated αSyn, a key component of Lewy bodies.
- αSyn triggers LPS-independent priming and activation of the microglial NLRP3 inflammasome.
- Fyn kinase mediates PKCδ-dependent NF-κB-p65 nuclear translocation for inflammasome priming and facilitates αSyn import, leading to mitochondrial ROS generation and inflammasome activation.
Conclusions:
- Identified a novel Fyn kinase-mediated signaling pathway that amplifies neuroinflammation in Parkinson's disease.
- This pathway involves the regulation of αSyn uptake and NLRP3 inflammasome activation by Fyn kinase and CD36.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Positive Regulator Molecules
Export of Misfolded Proteins out of the ER
Enteric Nervous System: Regulation of GI Motor Activity
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...

